Sophia McKinley, MD, EdM, on the Role of Adjuvant Immunotherapy for High-Risk Cutaneous Melanoma

Posted: Tuesday, April 23, 2024

Sophia McKinley, MD, EdM, of Massachusetts General Hospital, discusses recurrence of cutaneous melanoma after adjuvant immunotherapy for patients with high-risk, resected disease, differences in overall survival based on the type of immunotherapy used, and the focus of future clinical trials for this patient population.

---